Mechanisms of mutant SOD1 induced mitochondrial toxicity in amyotrophic lateral sclerosis

Piia Vehviläinen1, Jari Koistinaho1, Goldsteins Gundars1

  • 1Department of Neurobiology, A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland Kuopio, Finland.

Insights

Mitochondrial dysfunction in amyotrophic lateral sclerosis (ALS) is linked to mutant Cu/Zn-superoxide dismutase 1 (SOD1). Misregulation of SOD1 activity within mitochondria contributes to disease progression.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Mitochondrial dysfunction is a key factor in amyotrophic lateral sclerosis (ALS) pathology.
  • Oxidative stress, indicated by increased reactive oxygen species (ROS) and damage, is observed in ALS patients and models.
  • The precise origin of oxidative stress in ALS has remained unclear.

Purpose of the Study:

  • To explore the role of mutant Cu/Zn-superoxide dismutase 1 (mutSOD1) in mitochondrial dysfunction in ALS.
  • To investigate the mechanisms by which mutSOD1 contributes to ALS pathology.
  • To highlight the misregulation of SOD1 activity in the mitochondrial intermembrane space (IMS) as a key toxic mechanism.

Main Methods:

  • Review of current in vitro and in vivo evidence on mutSOD1 and mitochondrial function.
  • Analysis of the association of mutSOD1 with mitochondria in ALS models and patients.
  • Discussion of the localization and activity of mutSOD1 within the mitochondrial intermembrane space.

Main Results:

  • Mutant SOD1 (mutSOD1) significantly associates with mitochondria in ALS, particularly in the spinal cord.
  • Increased recruitment of mutSOD1 to mitochondria precedes disease onset in animal models.
  • Localization of mutSOD1 to the mitochondrial intermembrane space (IMS) impairs mitochondrial functions.

Conclusions:

  • Misregulation of dismutase activity of SOD1 within the mitochondrial IMS is a major mechanism of toxicity in ALS.
  • Mutant SOD1's interaction with mitochondria is a critical factor in ALS pathogenesis.
  • Understanding mutSOD1's role in mitochondrial dysfunction offers novel therapeutic perspectives for ALS.

Related Concept Videos

ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
16.0K
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
26
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
11.9K